Global Gadobutrol Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Gadobutrol Market Insights, Forecast to 2034
Gadobutrol (CAS 138071-82-6)
Global Gadobutrol market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gadobutrol industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Gadobutrol key manufacturers include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), BOC Sciences, LGM Pharma, Advanced Technology & Industrail and MedKoo Biosciences, etc. Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Gadobutrol were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Gadobutrol market and estimated to attract more attentions from industry insiders and investors.
Gadobutrol can be divided into Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) and Pharmacy Bulk Packages (30 mL and 65 mL), etc. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Gadobutrol is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Gadobutrol industry development. In 2022, global % sales of Gadobutrol went into Adults filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Gadobutrol market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gadobutrol market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Adults
Children
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Gadobutrol plant distribution, commercial date of Gadobutrol, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Gadobutrol introduction, etc. Gadobutrol Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Gadobutrol
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Gadobutrol market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gadobutrol industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Gadobutrol key manufacturers include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), BOC Sciences, LGM Pharma, Advanced Technology & Industrail and MedKoo Biosciences, etc. Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Gadobutrol were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Gadobutrol market and estimated to attract more attentions from industry insiders and investors.
Gadobutrol can be divided into Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) and Pharmacy Bulk Packages (30 mL and 65 mL), etc. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Gadobutrol is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Gadobutrol industry development. In 2022, global % sales of Gadobutrol went into Adults filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Gadobutrol market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gadobutrol market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Segment by Application
Adults
Children
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Gadobutrol plant distribution, commercial date of Gadobutrol, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Gadobutrol introduction, etc. Gadobutrol Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Gadobutrol
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports